Thrombotic events are rare complications during anticoagulation therapy. Th
e thrombosis varies from localized cutaneous involvement to catastrophic th
romboembolism and is usually associated with an underlying thrombophilia. W
e describe a patient who developed skin necrosis during warfarin treatment
for a pulmonary thromboembolism. The management was complicated by the deve
lopment of heparin-induced thrombocytopenia and further thrombotic events.
Thrombophilia screen demonstrated the presence of protein S deficiency and
Factor V Leiden as the prothrombotic factors, together with the demonstrati
on of antiplatelet factor 4 antibodies, which confirms the diagnosis of hep
arin-induced thrombocytopenia (type II). Reinstitution of warfarin at a low
loading dose was successful without the recurrence of skin lesions nor any
further thrombosis.